Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1994 1
1997 1
2001 6
2002 2
2003 1
2004 1
2005 2
2009 2
2010 3
2011 2
2012 1
2013 1
2016 1
2017 2
2018 2
2019 3
2020 5
2021 7
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean e pierantoni[Author] (172 results)?
Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.
Rossi D, Catallo MR, Pierantozzi E, Sorrentino V. Rossi D, et al. Among authors: pierantozzi e. J Gen Physiol. 2022 Sep 5;154(9):e202213115. doi: 10.1085/jgp.202213115. Epub 2022 Aug 18. J Gen Physiol. 2022. PMID: 35980353 Free PMC article. Review.
In skeletal muscle, Ca2+ necessary for muscle contraction is stored and released from the sarcoplasmic reticulum (SR), a specialized form of endoplasmic reticulum through the mechanism known as excitation-contraction (E-C) coupling. Following activation of skeletal muscle …
In skeletal muscle, Ca2+ necessary for muscle contraction is stored and released from the sarcoplasmic reticulum (SR), a specialized form of …
Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?
Stefani A, Pierantozzi M, Cardarelli S, Stefani L, Cerroni R, Conti M, Garasto E, Mercuri NB, Marini C, Sucapane P. Stefani A, et al. Among authors: pierantozzi m. Front Neurosci. 2022 Mar 25;16:846681. doi: 10.3389/fnins.2022.846681. eCollection 2022. Front Neurosci. 2022. PMID: 35401084 Free PMC article. Review.
So far, experimental protocols are verifying the clinical extension to other facets of the movement disorder galaxy (i.e., internal pallidus for disabling dyskinesias). Aside from those neurosurgical options, one of the most intriguing opportunities of this technique relie …
So far, experimental protocols are verifying the clinical extension to other facets of the movement disorder galaxy (i.e., internal p …
Quantitative Ultrafast Electron-Temperature Dynamics in Photo-Excited Au Nanoparticles.
Sygletou M, Benedetti S, Ferrera M, Pierantozzi GM, Cucini R, Della Valle G, Carrara P, De Vita A, di Bona A, Torelli P, Catone D, Panaccione G, Canepa M, Bisio F. Sygletou M, et al. Among authors: pierantozzi gm. Small. 2021 Jul;17(26):e2100050. doi: 10.1002/smll.202100050. Epub 2021 Jun 1. Small. 2021. PMID: 34061425 Free article.
Systemic activation of Nrf2 pathway in Parkinson's disease.
Petrillo S, Schirinzi T, Di Lazzaro G, D'Amico J, Colona VL, Bertini E, Pierantozzi M, Mari L, Mercuri NB, Piemonte F, Pisani A. Petrillo S, et al. Among authors: pierantozzi m. Mov Disord. 2020 Jan;35(1):180-184. doi: 10.1002/mds.27878. Epub 2019 Nov 4. Mov Disord. 2020. PMID: 31682033
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process.
Stefani A, Olivola E, Stampanoni Bassi M, Pisani V, Imbriani P, Pisani A, Pierantozzi M. Stefani A, et al. Among authors: pierantozzi m. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):538-46. doi: 10.2174/1871527311312040016. CNS Neurol Disord Drug Targets. 2013. PMID: 23574170 Review.
For synucleinopathies, we will discuss the possibility to detect factors directly involved in earliest disease pathology (alpha-synuclein, tau-proteins) together with indexes of disease progression (i.e. dopamine-metabolite ratio and loss of blood-brain barrier integrity). …
For synucleinopathies, we will discuss the possibility to detect factors directly involved in earliest disease pathology (alpha-synuclein, t …
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence.
Schirinzi T, Martella G, Imbriani P, Di Lazzaro G, Franco D, Colona VL, Alwardat M, Sinibaldi Salimei P, Mercuri NB, Pierantozzi M, Pisani A. Schirinzi T, et al. Among authors: pierantozzi m. Front Neurol. 2019 Feb 26;10:148. doi: 10.3389/fneur.2019.00148. eCollection 2019. Front Neurol. 2019. PMID: 30863359 Free PMC article.
Vitamin E might indeed compensate PINK1 haploinsufficiency and mitochondrial impairment, reverting some central steps of the pathogenic process. Altogether, both clinical and experimental findings suggest that Vitamin E could be a potential, useful agent for PD pati …
Vitamin E might indeed compensate PINK1 haploinsufficiency and mitochondrial impairment, reverting some central steps of the pathogen …
A biological characterization of patients with postmenopausal Parkinson's disease.
Bovenzi R, Schirinzi T, Conti M, Sancesario GM, Zenuni H, Simonetta C, Bissacco J, Mascioli D, Pieri M, Cerroni R, Stefani A, Mercuri NB, Pierantozzi M. Bovenzi R, et al. Among authors: pierantozzi m. J Neurol. 2024 Jun;271(6):3610-3615. doi: 10.1007/s00415-024-12258-8. Epub 2024 Mar 16. J Neurol. 2024. PMID: 38492015
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis.
Singh B, Lant S, Cividini S, Cattrall JWS, Goodwin LC, Benjamin L, Michael BD, Khawaja A, Matos AMB, Alkeridy W, Pilotto A, Lahiri D, Rawlinson R, Mhlanga S, Lopez EC, Sargent BF, Somasundaran A, Tamborska A, Webb G, Younas K, Al Sami Y, Babu H, Banks T, Cavallieri F, Cohen M, Davies E, Dhar S, Fajardo Modol A, Farooq H, Harte J, Hey S, Joseph A, Karthikappallil D, Kassahun D, Lipunga G, Mason R, Minton T, Mond G, Poxon J, Rabas S, Soothill G, Zedde M, Yenkoyan K, Brew B, Contini E, Cysique L, Zhang X, Maggi P, van Pesch V, Lechien J, Saussez S, Heyse A, Brito Ferreira ML, Soares CN, Elicer I, Eugenín-von Bernhardi L, Ñancupil Reyes W, Yin R, Azab MA, Abd-Allah F, Elkady A, Escalard S, Corvol JC, Delorme C, Tattevin P, Bigaut K, Lorenz N, Hornuss D, Hosp J, Rieg S, Wagner D, Knier B, Lingor P, Winkler AS, Sharifi-Razavi A, Moein ST, SeyedAlinaghi S, JamaliMoghadamSiahkali S, Morassi M, Padovani A, Giunta M, Libri I, Beretta S, Ravaglia S, Foschi M, Calabresi P, Primiano G, Servidei S, Biagio Mercuri N, Liguori C, Pierantozzi M, Sarmati L, Boso F, Garazzino S, Mariotto S, Patrick KN, Costache O, Pincherle A, Klok FA, Meza R, Cabreira V, Valdoleiros SR, Oliveira V, Kaimovsky … See abstract for full author list ➔ Singh B, et al. Among authors: pierantozzi m. PLoS One. 2022 Jun 2;17(6):e0263595. doi: 10.1371/journal.pone.0263595. eCollection 2022. PLoS One. 2022. PMID: 35653330 Free PMC article.
53 results